Delivering a RAS protease halts tumor growth
Delivering a RAS protease halts tumor growth |
|
https://doi.org/10.18632/oncotarget.27714
Vania Vidimar,
Roman A. Melnyk,
and Karla J.F. Satchell
|
| 3265-3266 |
Targeting 14-3-3ε-CDC25A interactions to trigger apoptotic cell death in skin cancer
Targeting 14-3-3ε-CDC25A interactions to trigger apoptotic cell death in skin cancer |
|
https://doi.org/10.18632/oncotarget.27700
Thomas R. Holmes,
Jenan Al-Matouq,
Matti Holmes,
Lauren Nicola,
Justin C. Rudd,
Sándor Lovas,
and Laura A. Hansen
|
| 3267-3278 |
Sequencing for an interdisciplinary molecular tumor board in patients with advanced breast cancer: experiences from a case series
Sequencing for an interdisciplinary molecular tumor board in patients with advanced breast cancer: experiences from a case series |
|
https://doi.org/10.18632/oncotarget.27704
Christina Walter,
Andreas Hartkopf,
Andre Koch,
Marion Klaumünzer,
Martin Schulze,
Eva-Maria Grischke,
Florin-Andrei Taran,
Sara Brucker,
Florian Battke,
and Saskia Biskup
|
| 3279-3285 |
Ghrelin ameliorates tumor-induced adipose tissue atrophy and inflammation via Ghrelin receptor-dependent and -independent pathways
Ghrelin ameliorates tumor-induced adipose tissue atrophy and inflammation via Ghrelin receptor-dependent and -independent pathways |
|
https://doi.org/10.18632/oncotarget.27705
Haiming Liu,
Jiaohua Luo,
Bobby Guillory,
Ji-an Chen,
Pu Zang,
Jordan K. Yoeli,
Yamileth Hernandez,
Ian (In-gi) Lee,
Barbara Anderson,
Mackenzie Storie,
Alison Tewnion,
and Jose M. Garcia
|
| 3286-3302 |
The temporal effects of topical NF-κB inhibition, in the in vivo prevention of bile-related oncogenic mRNA and miRNA phenotypes in murine hypopharyngeal mucosa: a preclinical model
The temporal effects of topical NF-κB inhibition, in the in vivo prevention of bile-related oncogenic mRNA and miRNA phenotypes in murine hypopharyngeal mucosa: a preclinical model |
|
https://doi.org/10.18632/oncotarget.27706
Dimitra P. Vageli,
David Kasle,
Sotirios G. Doukas,
Panagiotis G. Doukas,
and Clarence T. Sasaki
|
| 3303-3314 |
Therapeutic applications of the selective high affinity ligand drug SH7139 extend beyond non-Hodgkin’s lymphoma to many other types of solid cancers
Therapeutic applications of the selective high affinity ligand drug SH7139 extend beyond non-Hodgkin’s lymphoma to many other types of solid cancers |
|
https://doi.org/10.18632/oncotarget.27709
Rod Balhorn,
and Monique Cosman Balhorn
|
| 3315-3349 |
Correction: Non-toxic dose of liposomal honokiol suppresses metastasis of hepatocellular carcinoma through destabilizing EGFR and inhibiting the downstream pathways
Correction: Non-toxic dose of liposomal honokiol suppresses metastasis of hepatocellular carcinoma through destabilizing EGFR and inhibiting the downstream pathways |
|
https://doi.org/10.18632/oncotarget.27369
Jianhong Yang,
Heying Pei,
Hong Luo,
Afu Fu,
Hansuo Yang,
Jia Hu,
Chengjian Zhao,
LuLu Chai,
Xiang Chen,
Ximing Shao,
Chunyu Wang,
Wenshuang Wu,
Li Wan,
Haoyu Ye,
Qiang Qiu,
Aihua Peng,
Yuquan Wei,
Li Yang,
and Lijuan Chen
|
| 3350-3351 |
